Redwood City, CA, United States of America

Barbara Jagodzinska

This inventor holds 18 USPTO granted patents and 14 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Neurological Treatments. Top assignees: Elan Pharmaceuticals, Inc., Pharmacia & Upjohn Company, University of California. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barbara Jagodzinska. Retrieved from https://idiyas.com/inventor/barbara-jagodzinska

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 14)

% Patents Active = 44.4

CIPO Patents = 3 (Patent Applications = 9)

EPO Patents = 4 (Patent Applications = 17)

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 116(Granted Patents)

Location History:

Redwood City, CA (US) (2005 - 2021)
Culver City, CA (US) (2021 - 2022)

Company Filing History:

11 out of 202

Elan Pharmaceuticals, Inc.

patents

5 out of 523

Pharmacia & Upjohn Company

patents

5 out of 16,058

University of California

where one patent can have more than one assignee

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

Muscular Dystrophies

Neurological Diseases

Alzheimer's Disease

Corticotropin-Releasing Factor

Cognitive Enhancement

Protease Inhibitors

Oxidative Metabolism

Triazolopyridines

Stress-Induced p-Tau

Aspartyl Protease Inhibitors

Hydroxyethylamine Derivatives

Amino Carboxamides

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12741939 - Compositions and methods for treating muscular dystrophies (2026-09-22),

2. 12728128 - Compositions and methods for the treatment of neurological diseases and disorders (2026-09-08),

3. 12441716 - Compositions and methods for increasing muscle mass and oxidative metabolism (2025-10-14),

4. 12157740 - Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau (2024-12-03),

5. 11370793 - Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau (2022-06-28),

6. 11142505 - Compositions for APP-selective BACE inhibition and uses therefor (2021-10-12),

7. 11077108 - Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition (2021-08-03),

8. 7906556 - Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors (2011-03-15),

9. 7858642 - Substituted hydroxyethylamine aspartyl protease inhibitors (2010-12-28),

10. 7727997 - N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives (2010-06-01),

11. 7498436 - Substituted hydroxyethylamines (2009-03-03),

12. 7385085 - Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors (2008-06-10),

13. 7338965 - 3,4-disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines (2008-03-04),

14. 7294642 - 1,3-Diamino-2-hydroxypropane pro-drug derivatives (2007-11-13),

15. 7214715 - Compounds to treat Alzheimer's disease (2007-05-08),

Title: Barbara Jagodzinska - Pioneering Inventor from Redwood City

Introduction: Barbara Jagodzinska is a trailblazing inventor based in Redwood City, California, known for her innovative contributions to various industries.

Latest Patents: Barbara Jagodzinska holds several cutting-edge patents in the fields of biotechnology, renewable energy, and consumer electronics.

Career Highlights: With over two decades of experience in research and development, Barbara has led numerous successful projects that have resulted in groundbreaking inventions with real-world applications.

Collaborations: Throughout her career, Barbara Jagodzinska has collaborated with top research institutions, leading companies, and talented inventors to push the boundaries of innovation further.

Conclusion: Barbara Jagodzinska's passion for innovation and her dedication to creating impactful solutions have solidified her reputation as a pioneering inventor in Redwood City and beyond.

Profile summary based on public USPTO records.